expand/collapse risk warning

CFDs come with a high risk of losing money rapidly due to leverage. 71% of accounts lose money when trading CFDs with this provider. You should understand how CFDs work and consider if you can take the risk of losing your money.

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 71% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

71% of retail investor accounts lose money when trading CFDs with this provider.


Abbott Labs Stock

[[ data.name ]]

[[ data.ticker ]]

[[ data.price ]] [[ data.change ]] ([[ data.changePercent ]]%)

Low: [[ data.low ]]

High: [[ data.high ]]







Founded by Chicago physician Wallace Calvin Abbott in 1888 and listed since 1929, Abbott Laboratories (ABT.US), is a global healthcare leader dedicated to enhancing people's lives through the development of diversified healthcare products and technologies. With a longstanding commitment to research and innovation.

Abbott provides an array of solutions spanning nutrition, diagnostics, medical devices, and branded generic pharmaceuticals. Headquartered in Abbott Park, Illinois, the company has 115,000 employees and operates in over 160 countries, consistently striving to make a lasting impact by addressing some of the world's most pressing health challenges.

As of August 2023, its market capitalization is 182.73B USD.

Abbott Laboratories has stood as a cornerstone in the healthcare sector, with its stock reflecting both the company's internal achievements and the broader economic tides.

Throughout the mid-2010s, Abbott's stock benefited from a series of successful acquisitions and product launches. The approval and success of the FreeStyle Libre glucose monitoring system was a particular highlight, marking Abbott's prowess in the medical devices sector. Over recent years their share price has varied from a low of $64.03 in 2018 to an ATH of $140.74 in 2021.

​Abbott Laboratories, given its diversified product range across healthcare, faces competition from several prominent companies in various sectors.

Some primary competitors include Johnson & Johnson, Becton Dickinson, Nestlé, and Danone. Abbott's comprehensive product portfolio means that it faces competition across multiple fronts, but it also gives the company a diversified revenue stream.

Swap long [[ data.swapLong ]] points
Swap short [[ data.swapShort ]] points
Spread min [[ data.stats.minSpread ]]
Spread avg [[ data.stats.avgSpread ]]
Min contract size [[ data.minVolume ]]
Min step size [[ data.stepVolume ]]
Commission and Swap Commission and Swap
Leverage Leverage
Trading Hours Trading Hours

* The spreads provided are a reflection of the time-weighted average. Though Skilling attempts to provide competitive spreads during all trading hours, clients should note that these may vary and are susceptible to underlying market conditions. The above is provided for indicative purposes only. Clients are advised to check important news announcements on our Economic Calendar, which may result in the widening of spreads, amongst other instances.

The above spreads are applicable under normal trading conditions. Skilling has the right to amend the above spreads according to market conditions as per the 'Terms and Conditions'.

Trade [[data.name]] with Skilling

All Hassle-free, with flexible trade sizes and with zero commissions!*

  • Trade 24/5
  • Minimum margin requirements
  • No commission, only spread
  • Fractional shares available
  • Easy to use platform

*Other fees may apply.

Sign up

Why Trade [[data.name]]

Make the most of price fluctuations - no matter what direction the price swings and without capital restrictions that come with buying the underlying asset.


Capitalise on rising prices (go long)


Capitalise on falling prices (go short)


Trade with leverage
Hold larger positions than the cash you have at your disposal


Trade on volatility
No need to own the asset


No commissions
Just low spreads


Manage risk with in-platform tools
Ability to set take profit and stop loss levels